Production of herpes simplex virus type 1 thymidine kinase in the presence of thymidine analogues.
Treatment of herpes simplex virus type 1 (HSV-1) infected Vero, BHK, BHKtk- and LMtk- cells with 5-iodo-5'-amino-2',5'-dideoxyuridine (AIdUrd) caused increased synthesis of ICP36 and an increase in HSV-1 thymidine kinase (tk) activity at late times of infection. The overproduced ICP36 was identified as the HSV-1 encoded tk protein by immunoprecipitation. Whereas the thymidine analogue 5'-amino-5'-deoxythymidine (AdThd) caused an increase in HSV-1 tk synthesis and activity in wild type Vero and BHK cells, 5-iodo-2'-deoxyuridine (IdUrd) caused a similar increase only in tk- cells (LMtk-, BHKtk-). In vivo and in vitro stabilization studies using a [35S]methionine pulse-chase experiment or heat inactivation studies with purified HSV-1 tk revealed that stabilization of tk by the analogues could not account for the extent of the observed increase. Since overproduction of tk is observed only at late times of infection, it is suggested that the presence of these thymidine analogues in either the viral DNA or the cellular nucleotide pools is responsible for the observed differential effects.
D000818:Animals; D002460:Cell Line; D002522:Chlorocebus aethiops; D006224:Cricetinae; D015224:Dideoxynucleosides; D006801:Humans; D007065:Idoxuridine / Q000031:analogs & derivatives* / Q000378:metabolism*; D018139:Simplexvirus / Q000201:enzymology* / Q000378:metabolism; D013936:Thymidine / Q000031:analogs & derivatives* / Q000378:metabolism; D013937:Thymidine Kinase / Q000096:biosynthesis* / Q000302:isolation & purification
D015224:Dideoxynucleosides; C024082:5'-amino-5'-deoxythymidine; C021283:5'-amino-5-iodo-2',5'-dideoxyuridine; D013937:Thymidine Kinase; D007065:Idoxuridine; D013936:Thymidine